• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9553
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Complaint, Ill-Defined (2331)
Event Date 06/03/2019
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
(b)(6) clinical study.It was reported that patient experienced coronary syndrome.In (b)(6) 2019, the subject was referred for cardiac catheterization.The target lesion #1 was located in the proximal circumflex (cx) artery extending into the distal cx with 90% stenosis and was 62 mm long, with a reference vessel diameter of 2.5 mm.The target lesion was treated with pre-dilatation and placement of 2.50 mm x 32 mm study stent.Following post dilation, residual stenosis was 0%.Three days later, the subject was discharged on aspirin and other antiplatelet medication.In (b)(6) 2019, 45 days post index procedure, the subject experienced coronary syndrome and was hospitalized for further evaluation on the same day.The event was not treated medically and the outcome is unknown.No further information is currently available but has been requested.
 
Event Description
Promus premier china registry clinical study.It was reported that patient experienced coronary syndrome.In (b)(6) 2019, the subject was referred for cardiac catheterization.The target lesion #1 was located in the proximal circumflex (cx) artery extending into the distal cx with 90% stenosis and was 62 mm long, with a reference vessel diameter of 2.5 mm.The target lesion was treated with pre-dilatation and placement of 2.50 mm x 32 mm study stent.Following post dilation, residual stenosis was 0%.Three days later, the subject was discharged on aspirin and other antiplatelet medication.In (b)(6) 2019, 45 days post index procedure, the subject experienced coronary syndrome and was hospitalized for further evaluation on the same day.The event was not treated medically and the outcome is unknown.No further information is currently available but has been requested.It was further reported that in (b)(6) 2019, the subject experienced acute coronary syndrome and was discharged on the same day of hospitalization.
 
Manufacturer Narrative
Device is a combination product.
 
Event Description
Promus premier china registry clinical study it was reported that patient experienced coronary syndrome.In (b)(6) 2019, the subject was referred for cardiac catheterization.The target lesion #1 was located in the proximal circumflex (cx) artery extending into the distal cx with 90% stenosis and was 62 mm long, with a reference vessel diameter of 2.5 mm.The target lesion was treated with pre-dilatation and placement of 2.50 mm x 32 mm study stent.Following post dilation, residual stenosis was 0%.Three days later, the subject was discharged on aspirin and other antiplatelet medication.In (b)(6) 2019, 45 days post index procedure, the subject experienced coronary syndrome and was hospitalized for further evaluation on the same day.The event was not treated medically and the outcome is unknown.No further information is currently available but has been requested.It was further reported that in (b)(6) 2019, the subject experienced acute coronary syndrome and was discharged on the same day of hospitalization.It was later reported that the event was treated medically and considered to be recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8860898
MDR Text Key153268483
Report Number2134265-2019-09206
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 09/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/13/2020
Device Model Number9553
Device Catalogue Number9553
Device Lot Number0022401676
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/24/2019
Initial Date FDA Received08/05/2019
Supplement Dates Manufacturer Received08/06/2019
08/17/2020
Supplement Dates FDA Received08/28/2019
09/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age61 YR
-
-